Ubrogepant 50MG UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FASVR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,743
Award facts
- Contract value 100% obligated
- $25,743.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,743.16 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Ubrogepant 50mg unit dose tablets (10-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of January 15, 2026. AmerisourceBergen will perform the work at its corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
Ubrogepant is an acute migraine treatment medication, reflecting the Defense Logistics Agency's procurement of specialized pharmaceutical commodities to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the DLA and serves critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements across a broad spectrum of therapeutic domains, from diabetes medications to neurological treatments and pain management pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26FASVR?
SPE2DR26FASVR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FASVR worth?
The government has obligated $25,743 on SPE2DR26FASVR.
Is contract SPE2DR26FASVR an order under another contract?
Yes. SPE2DR26FASVR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FASVR competed?
The extent of competition for SPE2DR26FASVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award